Home › Forums › AWSIM Member Forum › AAFP and Family Doctors – what can we do? › Reply To: AAFP and Family Doctors – what can we do?
<span style=”font-weight: 400;”>Hi Glenna! Great to see you here, though I’m sorry about the circumstances. </span><span style=”font-weight: 400;”>
</span><span style=”font-weight: 400;”>
</span><span style=”font-weight: 400;”>This is so frustrating! </span><span style=”font-weight: 400;”>In bad news, I do want to point out that the “weight bias” workshop is taught by someone who prominently sells weight loss on her practice website so it’s very likely to be the “don’t treat fat people badly because fatness is a disease but do commit to eradicating fatness from the earth” talk that the weight loss industry is peddling right now. </span>
<span style=”font-weight: 400;”>Here are some suggestions for what might be helpful (I’m happy to help with any/of of this any way that I can, I know that we know each other a bit but for anyone else reading this, I’m not a physician but I’m an expert in the research and I teach it to physicians, including CME and Grand Rounds, so if I can be helpful feel free to reach out at </span><span style=”font-weight: 400;”>ragen@weightandhealthcare.com</span><span style=”font-weight: 400;”>.) </span>
<span style=”font-weight: 400;”>I think perhaps the most helpful thing would be to put together a weight-inclusive care CME for AAFP</span>
<span style=”font-weight: 400;”>For the “ob*sity” CME that you originally asked about:</span><span style=”font-weight: 400;”>
</span><span style=”font-weight: 400;”>
</span><span style=”font-weight: 400;”>Ask questions to AAFP about this:</span><span style=”font-weight: 400;”>
</span>
<span style=”font-weight: 400;”>They are claiming “Obesity is a primary driver of multiple chronic conditions, including cardiovascular disease, stroke, Type 2 diabetes, and obesity-associated cancers”</span>
<span style=”font-weight: 400;”>Where is this claim coming from? How did the research used to come up with this conclusion mitigate for confounding variables, particularly weight stigma, weight cycling, and healthcare inequalities? </span>
<span style=”font-weight: 400;”>Ask if they can please provide the research list that shows that the methods of weight loss that are recommended in the CME actually create significant, long-term (at least five years) weight loss and that the weight loss (and not the behavior changes) created actual health benefits. </span>
<span style=”font-weight: 400;”>Ask where the COI disclosures for the faculty are? Some of these doctors have taken thousands from weight loss pharma companies – as a group they’ve taken nearly $100,000 from Novo Nordisk and Eli Lilly! Below is the information I found from 2018-2024 with the OpenPayments website to check and a reminder that research has found that even payments less than $20 impact physician behavior (I have a list of that research here: </span><span style=”font-weight: 400;”>https://weightandhealthcare.substack.com/p/do-small-pharmaceutical-industry</span><span style=”font-weight: 400;”>) </span>
<b>
</b><b>Carolynn Francavilla Brown</b><span style=”font-weight: 400;”>, MD, FOMA, D-ABOM</span><span style=”font-weight: 400;”>
</span><span style=”font-weight: 400;”>https://openpaymentsdata.cms.gov/physician/1286612</span> <span style=”font-weight: 400;”>
</span><span style=”font-weight: 400;”>$78,770 – Eli Lilly</span>
<span style=”font-weight: 400;”>$1218.44 – Novo Nordisk</span>
<b>Meghan Sills, MD – MRMG </b>
<span style=”font-weight: 400;”>https://openpaymentsdata.cms.gov/physician/362183</span><span style=”font-weight: 400;”> </span>
<span style=”font-weight: 400;”>$7290.06 – Novo Nordisk</span><span style=”font-weight: 400;”>
</span><span style=”font-weight: 400;”>$268.23 – Eli Lilly</span>
<b>Catherine (Cate) Varney, DO, ABOM Diplomate </b>
<span style=”font-weight: 400;”>https://openpaymentsdata.cms.gov/physician/1308869</span> <span style=”font-weight: 400;”>
</span><span style=”font-weight: 400;”>$7622.86 – Eli Lilly</span><span style=”font-weight: 400;”>
</span><span style=”font-weight: 400;”>$271.64 – Novo Nordisk</span>
<b>Keisha Harvey Mansfield, MD</b><span style=”font-weight: 400;”> </span>
<span style=”font-weight: 400;”>https://openpaymentsdata.cms.gov/physician/1299605</span>
<span style=”font-weight: 400;”>$112.00 – Eli Lilly</span><span style=”font-weight: 400;”>
</span><span style=”font-weight: 400;”>$103.78 – Novo Nordisk</span>
<b>Andrea M. DeSantis, DO, FAAFP</b> <span style=”font-weight: 400;”>
</span><span style=”font-weight: 400;”>https://openpaymentsdata.cms.gov/physician/3167</span> <span style=”font-weight: 400;”>
</span><span style=”font-weight: 400;”>$249.91 – Novo Nordisk</span><span style=”font-weight: 400;”>
</span><span style=”font-weight: 400;”>$19.23 – Eli Lilly</span>
<span style=”font-weight: 400;”>Ecler Jaqua, MD, MBA, FAAFP, FACLM </span><span style=”font-weight: 400;”>
</span><span style=”font-weight: 400;”>https://openpaymentsdata.cms.gov/physician/4775828</span><span style=”font-weight: 400;”> </span>
<span style=”font-weight: 400;”>$22.37 – Eli Lilly
I hope that this is helpful!</span>